Literature DB >> 2327419

Cocaine-related medical problems: consecutive series of 233 patients.

S L Brody1, C M Slovis, K D Wrenn.   

Abstract

PURPOSE: Little information describing common cocaine-related medical problems is available. This study examined the nature, frequency, treatment, incidence of complications, and emergency department deaths of patients seeking medical care for acute and chronic cocaine-associated medical problems. PATIENTS AND METHODS: A consecutive series of 233 hospital visits by 216 cocaine-using patients over a 6-month period during 1986 and 1987 was studied. Medical records were retrospectively reviewed to determine patient characteristics, nature of complications, treatment, and outcome.
RESULTS: Patients most commonly used cocaine intravenously (49%), but freebase or crack use was also common (23.3%). Concomitant abuse of other intoxicants, especially alcohol, was frequently seen (48.5%). The vast majority of complaints were cardiopulmonary (56.2%), neurologic (39.1%), and psychiatric (35.8%); multiple symptoms were often present (57.5%). The most common complaint was chest pain though rarely was it believed to represent ischemia. Altered mental status was common (27.4%) and ranged from psychosis to coma. Short-term pharmacologic intervention was necessary in only 24% of patients, and only 9.9% of patients were admitted. Acute mortality was less than 1%.
CONCLUSION: Most medical complications of cocaine are short-lived and appear to be related to cocaine's hyperadrenergic effects. Patients usually do not require short-term therapy or hospital admission. Acute morbidity and mortality rates from cocaine use in patients presenting to the hospital are very low, suggesting that a major focus in the treatment of cocaine-related emergencies should be referral for drug abuse detoxification and treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327419     DOI: 10.1016/0002-9343(90)90484-u

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  53 in total

1.  Illicit drug use and emergency room utilization.

Authors:  K A McGeary; M T French
Journal:  Health Serv Res       Date:  2000-04       Impact factor: 3.402

2.  Satisfaction with access to health care among injection drug users, other drug users, and nonusers.

Authors:  Dale D Chitwood; Mary Comerford; H Virginia McCoy
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

3.  Electrophysiological actions of convulsants and anticonvulsants on neurons of the leech subesophageal ganglion.

Authors:  A L Kleinhaus
Journal:  Comp Biochem Physiol C Comp Pharmacol       Date:  1975-10-01

4.  Assessment of myocardial infarction by CT angiography and cardiovascular MRI in patients with cocaine-associated chest pain: a pilot study.

Authors:  K Paraschin; A Guerra De Andrade; J Rodrigues Parga
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

5.  Health care utilization among drug-using and non-drug-using women.

Authors:  Claire E Sterk; Katherine P Theall; Kirk W Elifson
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

6.  Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.

Authors:  Cm Hysek; Y Schmid; A Rickli; L D Simmler; M Donzelli; E Grouzmann; M E Liechti
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

7.  Prevalence of problematic cocaine consumption in a city of southern Europe, using capture-recapture with a single list.

Authors:  M T Brugal; A Domingo-Salvany; E Díaz de Quijano; L Torralba
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

Review 8.  Rethinking cocaine-associated chest pain and acute coronary syndromes.

Authors:  Jonathan B Finkel; Gregary D Marhefka
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

9.  Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.

Authors:  Gregory T Collins; Remy L Brim; Kathleen R Noon; Diwahar Narasimhan; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2012-04-19       Impact factor: 4.030

Review 10.  Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.